4 recruiting, 2 active not recruiting, 1 withdrawn. 3 Phase 2, 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Withdrawn 1 |
| Not applicable | 2 | Recruiting 2 |
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow B Lymphoblastic Lymphoma: new trials by email Literature Review of B Lymphoblastic Lymphoma trials Research Report on B Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia Activity Tracking, Biospecimen Collection, Cognitive Assessment - Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | Not applicable | Recruiting | University of Washington | 50 | 2025-10-15 | 2026-08-19 |
| CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ CAR T cell injection - B Lymphocytic Leukemia, B Lymphoblastic Lymphoma | Not applicable | Recruiting | Zhu Xiaofan | 60 | 2024-02-01 | 2024-04-09 |
| Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia Cyclophosphamide, Vincristine, Dexamethasone - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Active not recruiting | Alliance for Clinical Trials in Oncology | 68 | 2023-06-09 | 2026-07-10 |
| Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Recruiting | Children's Oncology Group | 5951 | 2019-10-31 | 2026-08-25 |
| A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 6720 | 2019-07-03 | 2026-10-01 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Asparaginase, Cyclophosphamide, Doxorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Withdrawn | University of Washington | 2018-07-01 | 2018-11-14 | |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia Blinatumomab, Cyclophosphamide, Cytarabine - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 80 | 2016-11-01 | 2026-05-20 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (7) · Burkitt Lymphoma (6) · Down Syndrome (1) · Leukemia, B-Cell (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (7) · Hemic and Lymphatic Diseases (7) · Immune System Diseases (7) · Immunoproliferative Disorders (7) · Leukemia (7) · Leukemia, Lymphoid (7) · Lymphatic Diseases (7) · Lymphoproliferative Disorders (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · DNA Virus Infections (6) · Epstein-Barr Virus Infections (6) · Herpesviridae Infections (6) · Infections (6) · Lymphoma, B-Cell (6)
Cyclophosphamide (5) · Doxorubicin (5) · Prednisone (5) · Vincristine (5) · Cytarabine (4) · Dexamethasone (4) · Mercaptopurine (4) · Methotrexate (4) · deltacortene (4) · prednylidene (4) · Asparaginase (3) · Calcium Dobesilate (3) · Inotuzumab Ozogamicin (3) · Methylprednisolone (3) · N,N-dicyclohexyl-isoborneol-10-sulfonamide (3)
University of Washington (2) · Alliance for Clinical Trials in Oncology (1) · Children's Oncology Group (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Zhu Xiaofan (1)
United States (6) · Puerto Rico (3) · Australia (2) · Canada (2) · New Zealand (2) · China (1)
Anna Halpern, MD (1) · Elias Jabbour (1) · Jennifer L McNeer (1) · Marlise R. Luskin, MD, MSCE (1) · Ryan Cassaday (1) · Sumit Gupta (1)
PMID 41671463, PMID 33191168, PMID 33844429, PMID 35622074, PMID 36279879, PMID 39651791
U10CA180886 (2), P30CA015704 (1), U10CA180821 (1)